LV10714B - Triazole compounds - Google Patents

Triazole compounds Download PDF

Info

Publication number
LV10714B
LV10714B LVP-93-1223A LV931223A LV10714B LV 10714 B LV10714 B LV 10714B LV 931223 A LV931223 A LV 931223A LV 10714 B LV10714 B LV 10714B
Authority
LV
Latvia
Prior art keywords
quot
formula
het
groups
compound
Prior art date
Application number
LVP-93-1223A
Other languages
English (en)
Latvian (lv)
Other versions
LV10714A (lv
Inventor
Dickinson Rodjer Peter
Richardson Kenneth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10642109&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LV10714(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of LV10714A publication Critical patent/LV10714A/xx
Publication of LV10714B publication Critical patent/LV10714B/lv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
LVP-93-1223A 1988-08-13 1993-11-15 Triazole compounds LV10714B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888819308A GB8819308D0 (en) 1988-08-13 1988-08-13 Triazole antifungal agents

Publications (2)

Publication Number Publication Date
LV10714A LV10714A (lv) 1995-06-20
LV10714B true LV10714B (en) 1995-12-20

Family

ID=10642109

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-1223A LV10714B (en) 1988-08-13 1993-11-15 Triazole compounds

Country Status (39)

Country Link
US (2) US5116844A (ro)
EP (1) EP0357241B1 (ro)
JP (2) JPH0786100B2 (ro)
KR (1) KR930002729B1 (ro)
CN (1) CN1029231C (ro)
AP (1) AP104A (ro)
AR (1) AR246963A1 (ro)
AU (1) AU602638B2 (ro)
BG (1) BG60865B1 (ro)
CA (1) CA1341325C (ro)
CY (1) CY1968A (ro)
CZ (1) CZ284318B6 (ro)
DD (1) DD284010A5 (ro)
DE (1) DE68913105T2 (ro)
DK (1) DK172471B1 (ro)
ES (1) ES2062009T4 (ro)
FI (1) FI96859C (ro)
GB (1) GB8819308D0 (ro)
HK (1) HK1000320A1 (ro)
HU (2) HU205348B (ro)
IE (1) IE61412B1 (ro)
IL (1) IL91231A (ro)
IN (1) IN175438B (ro)
IS (1) IS1586B (ro)
LV (1) LV10714B (ro)
MA (1) MA21610A1 (ro)
MX (1) MX17169A (ro)
MY (1) MY105092A (ro)
NO (1) NO174101C (ro)
NZ (1) NZ230283A (ro)
OA (1) OA09126A (ro)
PE (1) PE1591A1 (ro)
PL (2) PL162953B1 (ro)
PT (1) PT91440B (ro)
RO (1) RO108453B1 (ro)
RU (2) RU1836366C (ro)
SK (1) SK476189A3 (ro)
YU (1) YU47093B (ro)
ZA (1) ZA896151B (ro)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620342B2 (en) * 1987-09-24 1992-02-20 Philip Morris Products Inc. Smoking compositions containing a heteroaromatic flavorant-release additive
FI97382C (fi) * 1988-03-04 1996-12-10 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten 1,2,4-triatsolijohdannaisten valmistamiseksi
US5278175A (en) * 1990-02-02 1994-01-11 Pfizer Inc. Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
GB9107055D0 (en) * 1991-04-04 1991-05-22 Pfizer Ltd Triazole antifungal agents
US5493024A (en) * 1991-04-11 1996-02-20 Dowelanco 3,4,N-trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insectioides
GB9121456D0 (en) * 1991-10-10 1991-11-27 Pfizer Ltd Triazole antifungal agents
GB9317491D0 (en) * 1993-08-23 1993-10-06 Fujisawa Pharmaceutical Co New compound and a process for preparation thereof
SE508401C2 (sv) * 1993-06-09 1998-10-05 Sca Hygiene Prod Ab Absorberande struktur och absorberande alster, som innefattar strukturen ifråga
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
CA2145458A1 (en) * 1994-03-28 1995-09-29 Hiroki Kodama Triazole compound and production process and use thereof
GB9512961D0 (en) * 1995-06-26 1995-08-30 Pfizer Ltd Antifungal agents
CA2180091A1 (en) * 1995-07-08 1997-01-09 Hiroki Kodama Optically active triazole derivative, process for producing the same, antifungal agent, and method for using the same
ES2107376B1 (es) * 1995-08-02 1998-07-01 Uriach & Cia Sa J Nuevos derivados de pirimidona con actividad antifungica.
DE69611512T2 (de) * 1995-08-02 2001-05-31 J. Uriach & Cia. S.A., Barcelona Pyrimidonderivate mit antifungaler wirkung
WO1997005131A1 (en) * 1995-08-02 1997-02-13 J. Uriach & Cia. S.A. New carboxamides with antifungal activity
GB9516121D0 (en) * 1995-08-05 1995-10-04 Pfizer Ltd Organometallic addition to ketones
GB9605705D0 (en) * 1996-03-19 1996-05-22 Pfizer Ltd Therapeutic agents
US7193083B2 (en) * 1996-07-26 2007-03-20 Pfizer, Inc. Preparation of triazoles by organometallic addition to ketones and intermediates therefor
US6699853B2 (en) 1997-06-16 2004-03-02 Hoechst Schering Agrevo Gmbh 4-haloalkyl-3-heterocyclylpyridines, 4-haloalkyl-5-heterocyclyl-pyrimidines and 4-trifluoromethyl-3-oxadiazolylpyridines, processes for their preparation, compositions comprising them, and their use as pesticides
DE19725450A1 (de) 1997-06-16 1998-12-17 Hoechst Schering Agrevo Gmbh 4-Haloalkyl-3-heterocyclylpyridine und 4-Haloalkyl-5-heterocyclylpyrimidine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
GB9713149D0 (en) * 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
ES2159488B1 (es) * 2000-03-07 2002-04-16 Uriach & Cia Sa J Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica.
FR2814073B1 (fr) * 2000-09-21 2005-06-24 Yang Ji Chemical Company Ltd Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux derives de l'indole a titre de principes actifs d'une telle composition
KR100572996B1 (ko) * 2003-08-12 2006-04-25 한국화학연구원 불소화 비닐 에테르 측쇄기를 갖는 아졸계 살균제 화합물및 그의 제조방법
AR061889A1 (es) 2006-07-13 2008-10-01 Medichem Sa Proceso mejorado para la preparacion de voriconazol
EP2049504A4 (en) 2006-08-07 2010-09-22 Stiefel Laboratories ANTIFUNGAL CRYSTALLINE COMPOUNDS
WO2009137611A2 (en) * 2008-05-06 2009-11-12 Board Of Regents, The University Of Texas System Treatment of pulmonary fungal infection with voriconazole via inhalation
KR20120046242A (ko) * 2009-07-08 2012-05-09 바이엘 크롭사이언스 아게 치환된 페닐(옥시/티오)알칸올 유도체
WO2011064558A2 (en) 2009-11-30 2011-06-03 Cipla Limited Pharmaceutical composition
EP2545039A1 (en) 2010-03-10 2013-01-16 Synthon BV A process for making voriconazole
BR112012027308B1 (pt) * 2010-04-24 2021-07-06 Mycovia Pharmaceuticals, Inc. compostos inibidores de metaloenzima e composições compreendendo os mesmos
US9056855B2 (en) 2010-10-28 2015-06-16 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
RU2478106C2 (ru) * 2010-11-25 2013-03-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) СОЕДИНЕНИЯ НА ОСНОВЕ КОМПЛЕКСОВ ГИПЕРРАЗВЕТВЛЕННЫХ ПОЛИМЕРОВ Boltorn H, ОБЛАДАЮЩИЕ АНТИКАНДИДОЗНОЙ АКТИВНОСТЬЮ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
PL2678333T3 (pl) 2011-02-21 2015-08-31 Ranbaxy Laboratories Ltd Ulepszony sposób otrzymywania worykonazolu i jego produktów pośrednich
PL2720723T3 (pl) 2011-06-15 2018-10-31 Synthon Bv Stabilizowana kompozycja worykonazolu
UA114090C2 (uk) * 2011-06-19 2017-04-25 Вайамет Фармасьютікалс, Інк. Сполуки, що інгібують металоферменти
WO2012177608A1 (en) 2011-06-19 2012-12-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
AU2012273007A1 (en) * 2011-06-23 2014-01-30 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
TWI658039B (zh) * 2011-07-08 2019-05-01 維愛美製藥公司 金屬酶抑制劑化合物
TWI646088B (zh) * 2012-03-16 2019-01-01 維愛美製藥公司 金屬酶抑制劑化合物
US20150133472A1 (en) 2012-05-11 2015-05-14 Cipla Limited Pharmaceutical composition
CN102796087B (zh) * 2012-09-04 2015-04-15 西南大学 香豆素三唑醇及其制备方法和用途
EP2894981B1 (en) * 2012-09-12 2019-12-04 Dow AgroSciences LLC Metalloenzyme inhibitor compounds
DK2906555T3 (en) 2012-10-15 2017-02-06 Pfizer Ireland Pharmaceuticals Process for the preparation of voriconazole and analogs thereof
CA2913914C (en) * 2013-05-28 2018-03-20 Viamet Pharmaceuticals, Inc. Fungicidal compositions
RU2563811C1 (ru) * 2014-08-08 2015-09-20 Федеральное государственное бюджетное учреждение науки Институт химической физики им. Н.Н. Семенова Российской академии наук (ИХФ РАН) Фармацевтическая композиция для лечения грибковых заболеваний
CN107001338A (zh) * 2014-10-02 2017-08-01 拜耳作物科学股份公司 新的用作杀真菌剂的三唑衍生物
KR20180000731A (ko) 2015-05-18 2018-01-03 비아멧 파마슈티컬즈, 인코포레이티드 항진균성 화합물
EA202190092A1 (ru) 2018-06-21 2021-05-18 Юманити Терапьютикс, Инк. Композиции и способы лечения и профилактики неврологических расстройств

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0158741A3 (en) * 1980-11-19 1986-02-12 Imperial Chemical Industries Plc Intermediates for fungicidal triazole and imidazole compounds
US4510148A (en) * 1982-06-12 1985-04-09 Pfizer Inc. 2-Heterocyclic-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ols as antifungal agents
DE3228870A1 (de) * 1982-08-03 1984-02-09 Bayer Ag, 5090 Leverkusen Diazolyl-alkanole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
DE3242252A1 (de) * 1982-11-15 1984-05-17 Bayer Ag, 5090 Leverkusen Heterocyclisch substituierte hydroxyalkyl-azolyl-derivate
DE3242236A1 (de) * 1982-11-15 1984-05-17 Bayer Ag, 5090 Leverkusen "antimykotische mittel"
GB8304282D0 (en) * 1983-02-16 1983-03-23 Pfizer Ltd Antifungal agents
DE3307218A1 (de) * 1983-03-02 1984-09-06 Bayer Ag, 5090 Leverkusen Substituierte diazolylalkyl-carbinole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
GB8306351D0 (en) * 1983-03-08 1983-04-13 Ici Plc Azole fungicides
DK159205C (da) * 1983-03-16 1991-03-04 Pfizer Bis(triazol)alkanol-forbindelser, anvendelse af disse, farmaceutiske praeparater og landbrugsfungicider indeholdende disse og fremgangsmaade til behandling af planter eller froe, som har en svampeinfektion
GB8307232D0 (en) * 1983-03-16 1983-04-20 Pfizer Ltd Antifungal agents
GB8313235D0 (en) * 1983-05-13 1983-06-22 Pfizer Ltd Antifungal agents
DE3325313A1 (de) * 1983-07-13 1985-01-31 Bayer Ag, 5090 Leverkusen Fungizide mittel, deren herstellung und verwendung
US4483863A (en) * 1984-01-20 1984-11-20 Pfizer Inc. Triazole antifungal agents
IE58738B1 (en) * 1984-09-05 1993-11-03 Ici Plc Antifungal azole compounds
DE3440117A1 (de) * 1984-11-02 1986-05-15 Bayer Ag, 5090 Leverkusen Substituierte azolylcyclopropyl-azolylmethyl-carbinol-derivate
GB8506619D0 (en) * 1985-03-14 1985-04-17 Pfizer Ltd Triazole antifungal agents
ZA874485B (en) * 1986-06-23 1989-02-22 Du Pont Antifungal carbinols
DE3813841A1 (de) * 1987-06-03 1988-12-15 Bayer Ag Heterocyclische hydroxyethylazole
GB8716651D0 (en) * 1987-07-15 1987-08-19 Ici Plc 2-propanol derivatives
FI97382C (fi) * 1988-03-04 1996-12-10 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten 1,2,4-triatsolijohdannaisten valmistamiseksi

Also Published As

Publication number Publication date
JPH07173154A (ja) 1995-07-11
YU47093B (sh) 1994-12-28
SK280775B6 (sk) 2000-07-11
ES2062009T4 (es) 2006-07-01
KR900003157A (ko) 1990-03-23
HU211511A9 (en) 1995-11-28
IS3499A7 (is) 1990-02-14
DD284010A5 (de) 1990-10-31
ZA896151B (en) 1991-03-27
RU2095358C1 (ru) 1997-11-10
AP8900135A0 (en) 1989-10-31
AP104A (en) 1990-11-02
DE68913105T2 (de) 1994-05-26
FI96859C (fi) 1996-09-10
MX17169A (es) 1993-08-01
CY1968A (en) 1997-09-05
SK476189A3 (en) 2000-07-11
PL162953B1 (pl) 1994-01-31
DK394589A (da) 1990-02-14
YU158789A (en) 1991-04-30
FI893809A (fi) 1990-02-14
AU3893089A (en) 1990-03-22
LV10714A (lv) 1995-06-20
RU1836366C (ru) 1993-08-23
CZ284318B6 (cs) 1998-10-14
HU205348B (en) 1992-04-28
JPH02104583A (ja) 1990-04-17
AU602638B2 (en) 1990-10-18
PT91440A (pt) 1990-03-08
IE892582L (en) 1990-02-13
CA1341325C (en) 2001-12-11
PE1591A1 (es) 1991-03-16
EP0357241A1 (en) 1990-03-07
BG89519A (bg) 1993-12-24
CZ476189A3 (cs) 1998-09-16
IS1586B (is) 1996-03-01
FI96859B (fi) 1996-05-31
IL91231A (en) 1994-08-26
NO174101C (no) 1994-03-16
RO108453B1 (ro) 1994-05-31
BG60865B1 (bg) 1996-05-31
GB8819308D0 (en) 1988-09-14
MA21610A1 (fr) 1990-04-01
KR930002729B1 (ko) 1993-04-09
NZ230283A (en) 1991-02-26
IN175438B (ro) 1995-06-17
IE61412B1 (en) 1994-11-02
NO174101B (no) 1993-12-06
US5364938A (en) 1994-11-15
DE68913105D1 (de) 1994-03-24
MY105092A (en) 1994-08-30
ES2062009T3 (es) 1994-12-16
JP2713394B2 (ja) 1998-02-16
DK172471B1 (da) 1998-09-07
US5116844A (en) 1992-05-26
CN1029231C (zh) 1995-07-05
HUT52089A (en) 1990-06-28
EP0357241B1 (en) 1994-02-16
OA09126A (fr) 1991-10-31
PL163756B1 (pl) 1994-04-29
PT91440B (pt) 1995-05-04
NO893248L (no) 1990-02-14
HK1000320A1 (en) 1998-02-27
DK394589D0 (da) 1989-08-11
AR246963A1 (es) 1994-10-31
IL91231A0 (en) 1990-03-19
FI893809A0 (fi) 1989-08-11
JPH0786100B2 (ja) 1995-09-20
CN1040795A (zh) 1990-03-28
NO893248D0 (no) 1989-08-11

Similar Documents

Publication Publication Date Title
LV10714B (en) Triazole compounds
JP7104232B2 (ja) 芳香族スルホンアミド誘導体
JP2015505538A5 (ro)
Jadhav et al. Synthesis and biological evaluation of a series of 1, 4-disubstituted 1, 2, 3-triazole derivatives as possible antimicrobial agents
US7709469B2 (en) P2X7 receptor antagonists and methods of use
AU2009206468B2 (en) Fungicidal heterocyclic compounds
CA3006469C (en) Metalloenzyme inhibitor compounds
JP2014518220A5 (ro)
WO2009094407A2 (en) Fungicidal amides
JP2008526723A5 (ro)
US7816522B2 (en) Triazolone derivatives
JP2018507184A5 (ro)
JP2014513134A5 (ro)
ES2202453T3 (es) Agentes antifungicos de triazol.
JP2014518219A5 (ro)
HU211474A9 (en) Azole compounds, their production and use
KR20100047901A (ko) 암 및 건선 치료에 유용한 복소환 아미드
KR20100083196A (ko) 트리아졸 치환된 아릴아미드 유도체 및 p2x3 및/또는 p2x2/3 퓨린성 수용체 길항제로서의 용도
JP2001526187A5 (ro)
JP2018527325A5 (ro)
US20100099692A1 (en) Harmful organism control composition
AU2013277673A1 (en) Fungicidal heterocyclic compounds
AU2004275963B2 (en) Derivatives of 1,3-diones having a herbicidal activity
Shafiee et al. Synthesis and in vitro Antimicrobial Evaluation of 5‐(1‐Methyl‐5‐nitro‐2‐imidazolyl)‐4H‐1, 2, 4‐triazoles
HRP20141067T1 (hr) Derivat 1-heterodiena i sredstvo za kontrolu štetnih organizama